Ping Chu Selected Research

human MIRN143 microRNA

1/2022

Construction of Endometrial Carcinoma ceRNA Network and Screening of Key Genes Based on TCGA Database.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ping Chu Research Topics

Disease

6	Neoplasms (Cancer) 01/2022 - 09/2009
6	Tuberculosis (Tuberculoses) 01/2018 - 01/2013
3	Tularemia 01/2017 - 04/2010
3	Infections 01/2017 - 12/2012
2	Neuroblastoma 07/2019 - 01/2018
2	Carcinogenesis 06/2019 - 05/2018
2	Ovarian Neoplasms (Ovarian Cancer) 05/2018 - 11/2010
2	Poliomyelitis (Polio) 10/2013 - 06/2012
2	Syphilis 01/2013 - 12/2012
1	Polyps 08/2022
1	Endometrial Neoplasms (Endometrial Cancer) 01/2022
1	Pneumonia (Pneumonitis) 01/2021
1	Meningitis 01/2021
1	Deafness (Deaf Mutism) 02/2019
1	Inflammation (Inflammations) 01/2019
1	Neoplasm Metastasis (Metastasis) 05/2018
1	Papillary Thyroid Cancer 01/2018
1	Placenta Previa 01/2018
1	Shock 07/2017
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 07/2017
1	Cognitive Dysfunction 07/2017
1	Rhabdomyosarcoma 01/2017
1	Dyspnea (Shortness of Breath) 11/2016
1	Squamous Cell Carcinoma of Head and Neck 04/2016
1	Extrapulmonary Tuberculosis 04/2014
1	HIV Infections (HIV Infection) 01/2013
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2013
1	Melanoma (Melanoma, Malignant) 09/2011
1	Ovarian Epithelial Carcinoma 11/2010

Drug/Important Bio-Agent (IBA)

5	MicroRNAs (MicroRNA)IBA 01/2022 - 09/2011
5	VaccinesIBA 01/2017 - 04/2010
4	Proteins (Proteins, Gene)FDA Link 02/2019 - 01/2014
3	Biomarkers (Surrogate Marker)IBA 08/2022 - 01/2018
2	Long Noncoding RNAIBA 01/2022 - 07/2019
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 03/2015
2	Rifampin (Rifampicin)FDA LinkGeneric 01/2018 - 01/2017
2	Interleukin-10 (Interleukin 10)IBA 03/2015 - 04/2014
2	CytokinesIBA 04/2014 - 01/2014
1	Competitive Endogenous RNAIBA 01/2022
1	human MIRN424 micrornaIBA 01/2022
1	human MIRN211 microRNAIBA 01/2022
1	human MIRN143 microRNAIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2020
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 05/2018
1	Smad Proteins (Mothers Against Decapentaplegic Homolog)IBA 05/2018
1	TensinsIBA 05/2018
1	NestinIBA 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	hydroxide ionIBA 07/2017
1	Vitamin D FDA LinkGeneric 07/2017
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 07/2017
1	Insulin-Like PeptidesIBA 01/2017
1	Interleukin-8 (Interleukin 8)IBA 03/2015
1	LigandsIBA 03/2015
1	LipopeptidesIBA 03/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2015
1	Toll-Like Receptor 1IBA 03/2015
1	CXC ChemokinesIBA 03/2015
1	Attenuated VaccinesIBA 10/2014
1	Interleukin-4 (Interleukin 4)IBA 04/2014
1	Heroin (Diamorphine)IBA 01/2013
1	Pharmaceutical PreparationsIBA 01/2013
1	Synthetic DrugsIBA 01/2013
1	Methadone (Dolophine)FDA LinkGeneric 12/2012
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 12/2012
1	Neutralizing AntibodiesIBA 06/2012
1	Glycogen Synthase (Synthase I)IBA 09/2011
1	Gemcitabine FDA Link 11/2010
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2010
1	Ifosfamide FDA LinkGeneric 11/2010
1	Mitoxantrone (Novantrone)FDA LinkGeneric 11/2010
1	PlatinumIBA 11/2010
1	Epirubicin (Ellence)FDA LinkGeneric 11/2010
1	AnthracyclinesIBA 11/2010
1	IntegrinsIBA 09/2009

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2018 - 11/2010
1	Resuscitation 11/2016
1	Treatment Delay 01/2013
1	Combination Drug Therapy (Combination Chemotherapy) 11/2010
1	Therapeutics 09/2009